Adial Pharmaceuticals Inc

NASDAQ:ADIL   9:54:13 AM EDT
2.42
+0.02 (+0.83%)
Products

Adial Pharmaceuticals Says FDA Denied Co's Fast Track Request

Published: 06/24/2021 22:13 GMT
Adial Pharmaceuticals Inc (ADIL) - Adial Pharmaceuticals Provides Regulatory and Development Update.
Adial Pharmaceuticals Inc - Received Correspondence Related to Its Request for Fast Track Designation From FDA for Its Drug Candidate, Ad04.
Adial Pharmaceuticals Inc - Request for Fast Track Designation for Ad04 Has Been Denied at This Time by FDA.
Adial - FDA Stated Co Has Not Yet Demonstrated Ad04 Shows Potential to Address Unmet Medical Need in Situation Where Other Treatments Are Available.
Adial Pharmaceuticals Inc - Will Review Additional Requirements and Data Requested by FDA for a Fast Track Designation for Ad04.
Adial Pharmaceuticals Inc - FDA Did Acknowledge Unmet Medical Needs of Adolescents and Alcoholic Liver Disease Patients With Alcohol Use Disorder.